Mowoot, a CataloniaBio & HealthTech  member, has become the first Catalan medtech company to close a single  collaboration agreement with the largest funding platforms in Europe to launch its new round: Aescuvest (Germany), with the support of EITHealth, and Capital Cell, also CataloniaBio & HealthTech members. The new joint campaign totals 2 million euros.

Thanks to this unique collaboration, European investors of any size can invest in Mowoot through equity-funding with the assurance that the project has been reviewed and validated independently by both platforms. The new capital inflow will allow the company to boost its expansion plan focused on major European markets.

“We are very proud to be the first in this milestone, with the two largest European crowdfunding and digital venture capital platforms specializing in health, Aescuvest and Capital Cell. This collaboration reflects the international importance of our project and will provide us with the necessary funds to continue expanding in Europe ", says Dr. Markus Wilhelms, CEO and founder of Mowoot.

The medtech company, founded in Barcelona in 2014, specializes in the design and sale of medical devices.